Stay updated on Niraparib vs Placebo Maintenance in Platinum-Sensitive Ovarian Ca Clinical Trial
Sign up to get notified when there's something new on the Niraparib vs Placebo Maintenance in Platinum-Sensitive Ovarian Ca Clinical Trial page.

Latest updates to the Niraparib vs Placebo Maintenance in Platinum-Sensitive Ovarian Ca Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed study information about niraparib as maintenance therapy for platinum-sensitive ovarian cancer, while adding new collaborators and an updated revision number.SummaryDifference5%
- Check20 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check27 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check63 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.4%
- Check78 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference0.4%
- Check85 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.0%
Stay in the know with updates to Niraparib vs Placebo Maintenance in Platinum-Sensitive Ovarian Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib vs Placebo Maintenance in Platinum-Sensitive Ovarian Ca Clinical Trial page.